Author/Authors :
Asham ، Ozra Department of Cardiology - School of Medicine - Urmia University of Medical Sciences , Nezhad Alirezayi ، Arezoo Department of Cardiology - School of Medicine - Mazandaran University of Medical Sciences , Hadian ، Marjan Department of Cardiology - School of Medicine - Shahid Beheshti University of Medical Sciences , Mehralizadeh ، Neda Department of Cardiology - Rajayi Heart Center - Iran University of Medical Sciences
Abstract :
Background and aim: The present study was conducted to evaluate the effect of stem cell therapy on ischemic heart disease.Material and methods: All international databases, PubMed, Scopus, Science Direct, ISI, Web of Knowledge, and Embase were examined, searching until April 2023 based on keywords related to the objectives of the study. The current study was conducted based on the PRISMA 2020 checklist, and the Google Scholar search engine was also used to find related articles. The 95% confidence interval mean differences were calculated using the fixed effect model. Stata/MP v.17 software was used to conduct the meta-analysis.Results: After reviewing the abstracts of 320 articles, 98 articles were selected for full-text review, of which 20 articles were included in the meta-analysis. The left ventricular ejection fraction difference after stem-cell therapy compared to the control group was 8.29% (MD, 8.29 CI; 8.22,8.37; p lt;0.01). LVEF mean difference values in the ischemia/reperfusion MI model and chronic MI was 5.54% (MD, 5.54 CI; 5.43,5.65; p lt;0.01) and 10.65% (MD, 10.65 CI; 10.55,10.75; p lt;0.01).Conclusions: Based on the present meta-analysis, stem cell therapy on ischemic heart disease improves left ventricular ejection fraction.
Keywords :
Heart Diseases , Heart failure , Ischemia , Myocardial Infarction , stem cells
